Start with what matters.
Review a concise set of account priorities and the signals behind them. Bring sharper questions to your next account conversation.
Turn commercial complexity into clear priorities.
AI-assisted intelligence for the teams moving
life sciences forward.
Vantelys is being built to help pharmaceutical companies make sense of the signals inside their commercial data. We connect account-level evidence with the bigger territory picture.
From shifts in prescribing activity to competitive gaps, our approach translates complex analysis into focused weekly briefings—so commercial teams can see what deserves attention, and why.
See how Vantelys brings commercial data, account signals and weekly priorities into focus.
A clearer line from what changed to what your team should investigate next.
An account’s new-to-brand activity is softening while competitor activity is rising. Surface the divergence before it disappears in the territory total.
For pharmaceutical and life sciences companies seeking a more focused, evidence-led approach to commercial planning.
Review a concise set of account priorities and the signals behind them. Bring sharper questions to your next account conversation.
Understand where activity is concentrated and where account-level weakness may be hidden by the overall territory picture.
Translate supported metrics into a clear narrative, with transparent priority logic and visible gaps in the available data.
We believe the value of AI is in helping people see more clearly.
Vantelys brings that belief to commercial territory analysis.
Explore our approach to territory intelligence, ask questions, and discuss what matters to your commercial team.